期刊論文1. | Peduzzi, P.、Concato, J.、Kemper, E.、Holford, T. R.、Feinstein, A. R.(1996)。A simulation study of the number of events per variable in logistic regression analysis。Journal of Clinical Epidemiology,49(12),1373-1379。 |
2. | Clark, J. M.(2006)。The epidemiology of nonalcoholic fatty liver disease in adults。Journal of Clinical Gastroenterology,40(S1),S5-S10。 |
3. | Vancampfort, D.、Knapen, J.、Probst, M.、Scheewe, T.、Remans, S.、De Hert, M.(2012)。A systematic review of correlates of physical activity in patients with schizophrenia。Acta Psychiatrica Scandinavica,125(5),352-362。 |
4. | Serfaty, L.、Lemoine, M.(2008)。Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis。Diabetes Metab,34(6),634-637。 |
5. | Chalasani, N.、Younossi, Z.、Lavine, J. E.(2012)。The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology。Gastroenterology,142(7),1592-1609。 |
6. | Ong, J. P.、Pitts, A.、Younossi, Z. M.(2008)。Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease。Journal of Hepatology,49(4),608-612。 |
7. | Hou, X. H.、Zhu, Y. X.、Lu, H. J.(2011)。Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese。Journal of Gastroenterology and Hepatology,26(4),722-730。 |
8. | Silverman, J. F.、O'Brien, K. F.、Long, S.、Leggett, N.、Khazanie, P. G.、Pories, W. J.、Norris, H. T.、Caro, J. F.(1990)。Liver pathology in morbidly obese patients with and without diabetes。American Journal of Gastroenterology,85(10),1349-1355。 |
9. | Tsai, C. H.、Li, T. C.、Lin, C. C.(2008)。Metabolic syndrome as a risk factor for nonalcoholic fatty liver disease。Southern Medical Journal,101(9),900-905。 |
10. | Chen, C. H.、Huang, M. H.、Yang, J. C.(2006)。Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of Taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults。Journal of Clinical Gastroenterology,40(8),745-752。 |
11. | Newcomer, J. W.(2005)。Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review。CNS Drugs,19(Suppl 1),1-93。 |
12. | Hsu, J. H.、Chien, I. C.、Lin, C. H.(2014)。Increased risk of chronic liver disease in patients with schizophrenia: a population-based cohort study。Psychosomatics,55(2),163-171。 |
13. | Morlán-Coarasa, M. J.、Arias-Loste, M. T.、de la Foz, Victor Ortiz-Garcia(2016)。Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study。Psychopharmacology(Berl),233(23/24),3947-3952。 |
14. | Horacek, J.、Bubenikova-Valesova, V.、Kopecek, M.(2006)。Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia。CNS Drugs,20(5),389-409。 |
15. | Yan, J.、Hou, C.、Liang, Y.(2017)。The prevalence and risk factors of young male schizophrenics with non-alcoholic fatty liver disease。Neuropsychiatric Disease and Treatment,13,1493-1498。 |
16. | Xu, H.、Zhuang, X.(2019)。Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review。Neuropsychiatric Disease and Treatment,15,2087-2099。 |
17. | Franz, M.、Meyer, T.、Ehlers, F.(2002)。Schizophrenic patients, who still live in psychiatric hospitals despite decades of deinstitutionalization. Part 1 of the Hessian deinstitutionaisation study。Psychiatrische Praxis,29(5),245-250。 |
18. | Gardner, D. M.、Murphy, A. L.、O'Donnell, H.(2010)。International consensus study of antipsychotic dosing。American Journal of Psychiatry,167(6),686-693。 |
19. | Mantovani, A.、Petracca, G.、Beatrice, G.(2021)。Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials。Metabolites,11(2)。 |
20. | Joo, E. J.、Chang, Y.、Yeom, J. S.(2017)。Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: a cohort study。Hepatology,65(3),828-835。 |
21. | Huang, J.、Jing, M.、Wang, C.(2020)。The impact of hepatitis B virus infection status on the prevalence of nonalcoholic fatty liver disease: A population-based study。Journal of Medical Virology,92(8),1191-1197。 |
22. | Azarkar, G.、Doosti, Z.、Osmani, F.(2019)。Analysis of risk factors for nonalcoholic fatty-liver disease in hepatitis B virus infection: a casecontrol study。Hepatic Medicine,11,153-158。 |
23. | Zhong, G. C.、Wu, Y. L.、Hao, F. B.(2018)。Current but not past hepatitis B virus infection is associated with a decreased risk of nonalcoholic fatty liver disease in the Chinese population: a case-control study with propensity score analysis。Journal of Viral Hepatitis,25(7),842-852。 |
24. | Xiong, J.、Zhang, H.、Wang, Y.(2017)。Hepatitis B virus infection and the risk of nonalcoholic fatty liver disease: a meta-analysis。Oncotarget,8(63),107295-107302。 |
25. | Wong, V. W.、Wong, G. L.、Chu, W. C.(2012)。Hepatitis B virus infection and fatty liver in the general population。Journal of Hepatology,56(3),533-540。 |
26. | Machado, M. V.、Oliveira, A. G.、Cortez-Pinto, H.(2011)。Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients。Journal of Gastroenterology and Hepatology,26(9),1361-1367。 |
27. | Gurusamy, J.、Gandhi, S.、Damodharan, D.(2018)。Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: a systematic review。Asian Journal of Psychiatry,36,73-85。 |
28. | Kistler, K. D.、Brunt, E. M.、Clark, J. M.(2011)。Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease。American Journal of Gastroenterology,106(3),460-468。 |
29. | Ahmed, M. H.、Byrne, C. D.(2009)。Current treatment of non-alcoholic fatty liver disease。Diabetes, Obesity and Metabolism,11,188-195。 |
30. | Bellentani, S.(2017)。The epidemiology of non-alcoholic fatty liver disease。Liver International,37(Suppl 1),81-84。 |
31. | Boppidi, H.、Daram, S. R.(2008)。Nonalcoholic fatty liver disease: hepatic manifestation of obesity and themetabolic syndrome。Postgraduate Medicine,120,E01-E07。 |
32. | Assy, N.、Kaita, K.、Mymin, D.、Levy, C.、Rossor, B.、Minuk, G.(2000)。Fatty infiltration of liver in hyperlipidemic patients。Digestive Diseases and Sciences,45(10),1929-1934。 |
33. | Donati, G.、Stagni, B.、Piscaglia, F.、Venturoli, N.、Morselli-Labate, A. M.、Rasciti, L.(2004)。Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance。Gut,53(7),1020-1023。 |
34. | Gupte, P.、Amarapurkar, D.、Agal, S.、Baijal, R.、Kulshrestha, P.、Pramanik, S.(2004)。Non-alcoholic steatohepatitis in type 2 diabetes mellitus。Journal of Gastroenterology Hepatology,19(8),854-858。 |